Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes

Journal of Pharmacological Sciences

Volumn 120, Issue 3, 2012, Pages 176-186

  Takano, Katsura ^a   Yamasaki, Hiroshi ^a   Kawabe, Kenji ^a   Moriyama, Mitsuaki ^a   Nakamura, Yoichi ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Antidepressant drug; Astrocyte; Brain derived neurotrophic factor (BDNF); cAMP response element binding protein (CREB); Protein kinase A (PKA)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; IMIPRAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORADRENALIN; SEROTONIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

EID: 84869400266     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12039FP     Document Type: Article

References (49)

1. Slattery DA, Hudson AL, Nutt DJ. Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol. 2004;18:1-21. (Pubitemid 38200913)
2. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34:13-25. (Pubitemid 34270695)
3. Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther. 2008;117:30-51. (Pubitemid 350192670)
4. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33:88-109. (Pubitemid 350191319)
5. Duman RS, Malberg J, Nakagawa S, D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 2000;48:732-739.
6. Altar CA. Neurotrophins and depression. Trends Pharmacol Sci. 1999;20:59-61. (Pubitemid 29323957)
7. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919-2937.
8. Lessmann V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol. 1998;31:667-674. (Pubitemid 28520041)
9. McAllister AK, Lo DC, Katz LC. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron. 1995;15: 791-803.
10. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 1996;16:1137-1145. (Pubitemid 26227235)
11. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001;2:24-32.
12. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805-809. (Pubitemid 36962615)
13. Takei N, Sasaoka K, Inoue K, Takahashi M, Endo Y, Hatanaka H. Brain-derived neurotrophic factor increases the stimulationevoked release of glutamate and the levels of exocytosis-associated proteins in cultured cortical neurons from embryonic rats. J Neurochem. 1997;68:370-375. (Pubitemid 26427330)
14. Ventimiglia R, Mather PE, Jones BE, Lindsay RM. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci. 1995;7:213-222.
15. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA, et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett. 2006;398:215-219. (Pubitemid 43673698)
16. Palomino A, Vallejo-Illarramendi A, Gonzalez-Pinto A, Aldama A, Gonzalez-Gomez C, Mosquera F, et al. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Scizophr Res. 2006;86:321-322. (Pubitemid 44234056)
17. Castren E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Develop Neurobiol. 2010;70:289-297.
18. Yu H, Chen Z. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacologica Sinica. 2011;32:3-11.
19. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7:137-151. (Pubitemid 43151600)
20. Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry. 2007;12:1079-1088. (Pubitemid 350191365)
21. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10:1089-1093. (Pubitemid 47339961)
22. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22:3251-3261. (Pubitemid 35379212)
23. Castren E, Voikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007;7:18-21. (Pubitemid 46238033)
24. Russo-Neustadt AA, Chen MJ. Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des. 2005;11:1495-1510. (Pubitemid 40691448)
25. D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord. 2002;4:183-194. (Pubitemid 34591244)
26. Allaman I, Fiumelli H, Magistretti PJ, Martin J-L. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology. 2011;216:75-84.
27. Takano K, Sugita K, Moriyama M, Hashida K, Hibino S, Choshi T, et al. A dibenzoylmethane derivative protects against hydrogen peroxide-induced cell death and inhibits lipopolysaccharide-induced nitric oxide production in cultured rat astrocytes. J Neurosci Res. 2011;89:955-965.
28. Takasaki I, Takarada S, Tatsumi S, Azegami A, Yasuda M, Fukuchi M, et al. Extracellular adenosine 5'-triphosphate elicits the expression of brain-derived neurotrophic factor exon IV mRNA in rat astrocytes. Glia. 2008;56:1369-1379.
29. Wei R, Lin CM, Tu YY. Strain-specific BDNF expression of rat primary astrocytes. J Neuroimmunol. 2010;220:90-98.
30. Schreiber E, Matthias P, Muiller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419. (Pubitemid 19198635)
31. Kuramoto N, Inoue K, Gion K, Takano K, Sakata K, Ogita K, et al. Modulation of DNA binding of nuclear transcription factors with leucine-zipper motifs by particular endogenous polyamines in murine central and peripheral excitable tissues. Brain Res. 2003;967:170-180. (Pubitemid 36324299)
32. Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci. 2004;19:1699-1707. (Pubitemid 38482558)
33. Castren E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol. 2004;4:58-64. (Pubitemid 38145839)
34. Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 1998;352:1754-1755. (Pubitemid 28534964)
35. Barbacid M. The Trk family of neurotrophic receptors. J Neurobiol. 1994;25:1386-1403.
36. Chen F, Madsen TM, Wegener G, Nyengaard JR. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus. 2010;20:1376-1384.
37. Hwang J, Zheng LT, Ock J, Lee MG, Kim SH, Lee HW, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology. 2008;55:826-834.
38. Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK, et al. Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol. 2008;18:128-140. (Pubitemid 50016798)
39. Reus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, et al. Ketamine plus imipramine treatment induces antidepressant-like behavior and increase CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res. 2011;221:166-171.
40. Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci. 1992;12:4793-4799.
41. Schwartz J, Nishiyama N, Wilson D, Taniwaki T. Receptor-mediated regulation of neuropeptide gene expression in astrocyte. Glia. 1994;11:185-190. (Pubitemid 2116313)
42. Pellegri G, Magistretti P, Martin J. VIP and PACAP potentiate the action of glutamate on BDNF expression in mouse cortical neurons. Eur J Neurosci. 1998;10:270-280.
43. 2-adrenergic receptors. Neurochem Int. 2008;52:297-306.
44. Saha RN, Liu X, Pahan K. Up-regulation of BDNF in astrocytes by TNF-α: case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol. 2006;1:212-222. (Pubitemid 44244127)
45. Siamilis S. The level of ROS significantly correlates to BDNF protein level in spinal cord of rats: an exercise study. 2007;12th Annual Congress of the ECSS:11-14.
46. Ruffolo RR Jr, Goldberg MR, Morgan EL. Interations of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat. J Pharmacol Exp Ther. 1984;230:595-600. (Pubitemid 14040376)
47. Zhang WP, Ouyang M, Thomas SA. Potency of catecholamines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology. 2004;47:438-449. (Pubitemid 38953235)
48. 2+ response in patients with anorexia nervosa. Pharmacopsychiatry. 2008;41:10-16.
49. Hayashi T, Su TP. σ-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs. 2004;18:269-284. (Pubitemid 38526712)